3Salas-Alanis JC,Amaya-Guerra M,McGrath JA.The molecular basis of dystrophic epidermolysis bullosa in Mexico.Int J Dermatol 2000;39:436-442.
4Hovnanian A,Rochat A,Bodemer C,et al.Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.Am J Hum Genet 1997 ;61:599-610.
5Goto M,Sawamura D,Ito K,et al.Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.J Invest Dermatol 2006; 126:766-772.
6Ozanic Bulic S,Fassihi H,Mellerio JE,et al.Thalidomide in the management of epidermolysis bullosa pruriginosa.Br J Dermatol 2005; 152:1332-1334.
7Fine JD,Johnson LB,Weiner M,et al.Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa:results of a phase 1 trial of systemic isotretinoin.J Am Acad Dermatol 2004;50:563-571.
8Ingen-Housz-Oro S,Blanchet-Bardon C,Vrillat M,et al.Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa.J Eur Acad Dermatol Venereol 2004;8:649-653.
